Get the app
Industry

Amodei: cancer and Alzheimer's 'relics of the past' within a decade

In Anthropic's Nov 10 IPO roadshow video, Dario Amodei said AI will beat cancer, Alzheimer's, heart disease and mental illness within 10 years.

Dario Amodei is pitching cures, not chatbots, to Anthropic's would-be investors. In a 42-minute IPO roadshow video released on 10 November, the Anthropic CEO said: "Cancer, Alzheimer's, heart disease, mental illness — these will be relics of the past in, I think, less than a decade."

The claim isn't new, but the setting is. Amodei has argued since his 2024 essay Machines of Loving Grace that AI could pack 50–100 years of biomedical progress into 5–10 years. This time it is in an IPO pitch. Anthropic now has some evidence to point to. Its 27 October company update listed research partnerships with six drug-developing organisations, along with its own discovery programmes. In September it reported a Claude-led discovery of a CRISPR-like molecular system, though it admitted the system's function is still unclear.

The pushback has been quick. Vertex Pharmaceuticals chair Jeff Leiden told the WSJ that Vertex tested about 50 AI companies against a database of 10,000 compounds, and none produced a working drug on its own. He called sweeping AI cure timelines "complete BS." Former German health minister Karl Lauterbach and AI critic Gary Marcus argue that clinical trials and regulators can't move that fast. Amodei has said before that AI won't shorten trials.

Why it matters: the AI-for-biology promise is now part of Anthropic's IPO pitch, so investors can hold the company to it.

Sources

Independent coverage

Written by an AI pipeline from the sources above. Methodology · Report an error

The day's AI news, in one Telegram post.

The stories that matter for people who build with AI, with the source for every claim. Free, no spam.

Join on Telegram
The daily AI brief, on your phone.

Feed, daily deep-dive and bytes — readable offline, with push alerts for the topics you follow.

Get it on Google Play